Utility of 5-alpha-reductase inhibitors in active surveillance for favourable risk prostate cancer

INTRODUCTION: This retrospective review compares prostate-specific antigen (PSA) doubling time (DT) prior to the initiation of a 5-alpha-reductase inhibitor (pre-5-ARI) to after the PSA nadir (post-nadir) has been reached for patients on active surveillance for favourable-risk prostate cancer. METHO...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Chiang, Andrew S., Loblaw, D. Andrew, Jethava, Vibhuti, Sethukavalan, Perakaa, Zhang, Liying, Vesprini, Danny, Mamedov, Alexandre, Nam, Robert, Klotz, Laurence
Format: Artigo
Idioma:Inglês
Publicat: Canadian Medical Association 2013
Matèries:
Original Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3876449/
https://ncbi.nlm.nih.gov/pubmed/24381668
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5489/cuaj.262
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars